Dieulafoy lesion: endoscopic and surgical management.
Dieulafoy lesion is characterized by exteriorization of a large pulsatile arterial vessel through a minimal mucosal tear surrounded by normal mucosa, causing massive and recurrent upper digestive bleeding in previously healthy patients. More frequently presented than diagnosed, with the increase of its knowledge among endoscopists, a large number of cases are expected in the literature. Data from patients with upper gastrointestinal bleeding submitted to endoscopy at the Federal University of São Paulo, Gastrointestinal Endoscopy Unit from 1991 through 2002 were reviewed for Dieulafoy lesion. We found 15 patients with typical Dieulafoy gastric lesion. Their ages ranged from 18 to 78 years (mean age 49.9); 5 patients were female and 10 were male. Bleeding presented as hematemesis and melena in 7 cases (46.6%), hematemesis alone in 4 cases (26.6%), and melena alone in the other 4 cases (26.6%). Initial hemostatic approaches employed were: alcoholization (2 cases), epinephrine associated with alcohol injection (5 cases), sclerosis in 7 cases and surgery in 1 case. Dieulafoy lesion is a distinct nosologic entity that must be suspected in patients with massive digestive bleeding. Endoscopy became the procedure of choice for diagnosis and treatment of this disease.
Linhares
Marcelo M
MM
Department of Surgical Gastroenterology, Federal University of São Paulo, EPM-UNIFESP, Brazil. marbet@uol.com.br
Filho
Benedito H
BH
Schraibman
Vladimir
V
Goitia-Durán
Mario B
MB
Grande
José C D
JC
Sato
Nélson Y
NY
Lourenço
Laércio G
LG
Lopes-Filho
Gaspar D J
GD
D000293:Adolescent; D000328:Adult; D000368:Aged; D000438:Alcohols / Q000008:administration & dosage; D013505:Digestive System Surgical Procedures; D004837:Epinephrine / Q000008:administration & dosage; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000628:therapy*; D005773:Gastroscopy; D006489:Hemostatic Techniques; D006801:Humans; D008026:Ligation; D008297:Male; D008875:Middle Aged; D012597:Sclerosing Solutions / Q000008:administration & dosage; D013276:Stomach Ulcer / Q000150:complications / Q000628:therapy*; D014662:Vasoconstrictor Agents / Q000008:administration & dosage
D000438:Alcohols; D012597:Sclerosing Solutions; D014662:Vasoconstrictor Agents; D004837:Epinephrine